Related Experiment Videos

Liver injury and alterations of hepatic microsomal monooxygenase system due to dimethylformamide (DMF) in rats

K Imazu1, K Fujishiro, N Inoue

  • 1NTT Kitakyushu Hospital, Kitakyushu.

Fukuoka Igaku Zasshi = Hukuoka Acta Medica
|May 1, 1994
PubMed

Insights

Repeated N, N-dimethylformamide (DMF) exposure in rats caused liver swelling and elevated liver enzymes. Hepatic microsomal cytochrome P-450 and enzyme activities were altered, indicating DMF

Area of Science:

  • Toxicology
  • Hepatology
  • Biochemistry

Background:

  • N, N-dimethylformamide (DMF) is an industrial solvent with potential toxic effects.
  • Understanding DMF's impact on liver function and metabolism is crucial for occupational safety.

Purpose of the Study:

  • To investigate the effects of repeated N, N-dimethylformamide (DMF) exposure on rat liver and hepatic microsomal monooxygenase system.
  • To elucidate the pathogenesis of DMF-induced hepatotoxicity.

Main Methods:

  • Wistar male rats were administered DMF subcutaneously (0.5 ml/kg) daily for 1-17 days.
  • Liver weights, hematology, serum transaminases (GOT, GPT), and hepatic microsomal enzyme activities (cytochrome P-450, aminopyrine N-demethylase, aniline hydroxylase) were assessed.

Main Results:

  • Significant liver swelling and increased liver weights were observed after 3 days of DMF exposure.
  • Elevated serum transaminases (GOT, GPT) were noted after 3 and 7 days, decreasing by day 17.
  • Hepatic microsomal cytochrome P-450 levels decreased, and aminopyrine N-demethylase activity was significantly depressed, while aniline hydroxylase activity remained unchanged.

Conclusions:

  • Repeated DMF exposure alters the hepatic microsomal monooxygenase system in rats.
  • These alterations contribute to the understanding of DMF-induced liver damage.

Related Concept Videos